Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and ...

Here, doctors explain which COVID-19 vaccine is better when comparing Moderna, Pfizer, and Novovax. Plus, the efficacy of ...

Novavax's financial position improved significantly with a $570 million cash infusion from Sanofi. Find out why I remain ...

We recently compiled a list of the 7 Best Under The Radar Stocks to Buy According to Analysts. In this article, we are going ...

Shares of Novavax Inc. NVAX inched 0.15% higher to $13.04 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.45% ...

COVID-19 is a tricky virus, it changes and evolves all the time. So, as we learn in this story, we can’t let our guard down.

Novavax (NVAX) shares climbed 15% Wednesday after Jefferies released a bullish note on the company’s prospects after meeting ...

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Which COVID vaccine is better of the Pfizer, Modern and Novavax options? Here's how they compare with safety and efficacy and ...

The mRNA-based supplier of vaccines profited from Covid-19 vaccine sales. As the years passed, Covid evolved. The weaker ...

In terms of valuation, Novavax Inc’s market capitalization stands at $2.18 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value.